PT3443071T - Nova espécie bacteriana - Google Patents
Nova espécie bacterianaInfo
- Publication number
- PT3443071T PT3443071T PT177162534T PT17716253T PT3443071T PT 3443071 T PT3443071 T PT 3443071T PT 177162534 T PT177162534 T PT 177162534T PT 17716253 T PT17716253 T PT 17716253T PT 3443071 T PT3443071 T PT 3443071T
- Authority
- PT
- Portugal
- Prior art keywords
- bacterial species
- novel bacterial
- novel
- species
- bacterial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16164743 | 2016-04-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3443071T true PT3443071T (pt) | 2022-01-19 |
Family
ID=55755363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT177162534T PT3443071T (pt) | 2016-04-11 | 2017-04-11 | Nova espécie bacteriana |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US11202807B2 (pt) |
| EP (1) | EP3443071B1 (pt) |
| JP (1) | JP7012377B2 (pt) |
| KR (1) | KR20180133443A (pt) |
| CN (1) | CN109415683B (pt) |
| AU (1) | AU2017251253B2 (pt) |
| BR (1) | BR112018070962A2 (pt) |
| CA (1) | CA3020454A1 (pt) |
| DK (1) | DK3443071T3 (pt) |
| EA (1) | EA201800564A1 (pt) |
| ES (1) | ES2905784T3 (pt) |
| IL (1) | IL262258B (pt) |
| MX (1) | MX2018012408A (pt) |
| PL (1) | PL3443071T3 (pt) |
| PT (1) | PT3443071T (pt) |
| WO (1) | WO2017178496A1 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4249053A3 (en) | 2016-03-04 | 2024-06-19 | The Regents of The University of California | Microbial consortium and uses thereof |
| WO2017178496A1 (en) * | 2016-04-11 | 2017-10-19 | Wageningen Universiteit | Novel bacterial species |
| WO2019194130A1 (ja) * | 2018-04-05 | 2019-10-10 | 丸共バイオフーズ株式会社 | 新規ムチン型糖タンパク質およびその用途 |
| EP3773645A4 (en) | 2018-04-10 | 2021-11-24 | Siolta Therapeutics, Inc. | MICROBIAL CONSORTIA |
| CN110227085A (zh) * | 2019-07-16 | 2019-09-13 | 江苏省中医院 | Akkermansia Muciniphila在制备抗抑郁药物或者保健品中的应用 |
| KR102397916B1 (ko) * | 2019-10-01 | 2022-05-17 | (주)헬스바이옴 | 건강한 임산부 모유 유래 혐기성 인체 균주 및 이를 이용한 대사성 질환의 예방 또는 치료방법 |
| JP2022551201A (ja) | 2019-10-07 | 2022-12-07 | シオルタ・セラピューティクス，インコーポレイテッド | 治療用医薬組成物 |
| GB201915144D0 (en) * | 2019-10-18 | 2019-12-04 | Multigerm Uk Entpr Ltd | Method of promoting SCFA production by gut microbiota |
| CN111304133B (zh) * | 2020-03-20 | 2023-01-13 | 苏州普瑞森生物科技有限公司 | 一种培养嗜黏蛋白阿克曼氏菌的培养基及其使用方法和应用 |
| BE1029496B1 (fr) | 2021-08-19 | 2023-01-16 | The Akkermansia Company | Composition comprenant de l'Akkermansia muciniphila pasteurisée pour le traitement ou la prévention des troubles de la contractilité intestinale, en particulier des troubles de l'amplitude de la contractilité duodénale |
| BE1029502B1 (fr) | 2021-08-19 | 2023-01-17 | The Akkermansia Company | Composition comprenant de l'Akkermansia muciniphila pasteurisée pour le traitement ou la prévention de l'anxiété liée au syndrome du côlon irritable |
| KR102643788B1 (ko) * | 2021-12-08 | 2024-03-07 | (주)헬스바이옴 | 아커만시아속 미생물의 고수율 생산용 배지 조성물, 그를 이용한 배양방법 및 동결건조 방법 |
| TW202346570A (zh) * | 2022-05-20 | 2023-12-01 | 日商大塚製藥股份有限公司 | 屬於艾克曼氏菌(Akkermansia)屬之微生物 |
| CN115252651B (zh) * | 2022-06-08 | 2024-06-07 | 广州知易生物科技有限公司 | 嗜粘蛋白阿克曼菌在制备防治高血压的组合物中的应用和含有其的组合物 |
| FR3138770A1 (fr) * | 2022-08-10 | 2024-02-16 | Actina | Ensemble de parties destine a moduler le microbiote intestinale, reduire la prise de poids et le stockage des graisses dans le foie |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201401811WA (en) | 2011-08-30 | 2014-09-26 | Amc Amsterdam | Method for preventing and/or treating insulin resistance |
| CN104540962B (zh) * | 2012-08-01 | 2017-09-19 | 深圳华大基因研究院 | 糖尿病生物标志物及其应用 |
| WO2014075745A1 (en) | 2012-11-19 | 2014-05-22 | Université Catholique de Louvain | Use of akkermansia for treating metabolic disorders |
| US20140242654A1 (en) | 2013-02-26 | 2014-08-28 | Coskata, Inc. | Butyrate Producing Clostridium species, Clostridium pharus |
| US9669059B2 (en) | 2013-03-15 | 2017-06-06 | University Of Florida Research Foundation, Incorporated | Butyrogenic bacteria as probiotics to treat clostridium difficile |
| US10988509B2 (en) * | 2015-05-06 | 2021-04-27 | Wageningen Universiteit | Method of culturing Akkermansia |
| PT3347030T (pt) * | 2015-09-10 | 2021-08-19 | Univ Wageningen | Utilização de akkermansia pasteurizada para o tratamento de distúrbios metabólicos |
| JP2018534277A (ja) * | 2015-10-05 | 2018-11-22 | シュヴァイツェリッシェ フォルシュングスインスティテュート フュア ホーフゲブリクスクリーマ ウント メディツィン イン ダヴォス | 炎症性状態を治療するためのアッカーマンシア・ムシニフィラ（Ａｋｋｅｒｍａｎｓｉａ ｍｕｃｉｎｉｐｈｉｌａ）の使用 |
| CA3014525A1 (en) * | 2016-02-25 | 2017-08-31 | Caelus Pharmaceuticals B.V. | Compositions and methods for preventing and/or treating vitamin b12 deficiency |
| WO2017178496A1 (en) * | 2016-04-11 | 2017-10-19 | Wageningen Universiteit | Novel bacterial species |
| CN110551658A (zh) * | 2019-09-12 | 2019-12-10 | 君维安(武汉)生命科技有限公司 | 一种嗜黏蛋白阿克曼氏菌的低氧培养方法 |
-
2017
- 2017-04-11 WO PCT/EP2017/058700 patent/WO2017178496A1/en active Application Filing
- 2017-04-11 BR BR112018070962A patent/BR112018070962A2/pt unknown
- 2017-04-11 AU AU2017251253A patent/AU2017251253B2/en active Active
- 2017-04-11 JP JP2019503784A patent/JP7012377B2/ja active Active
- 2017-04-11 ES ES17716253T patent/ES2905784T3/es active Active
- 2017-04-11 DK DK17716253.4T patent/DK3443071T3/da active
- 2017-04-11 KR KR1020187031725A patent/KR20180133443A/ko not_active Application Discontinuation
- 2017-04-11 PL PL17716253T patent/PL3443071T3/pl unknown
- 2017-04-11 EA EA201800564A patent/EA201800564A1/ru unknown
- 2017-04-11 MX MX2018012408A patent/MX2018012408A/es unknown
- 2017-04-11 EP EP17716253.4A patent/EP3443071B1/en active Active
- 2017-04-11 CN CN201780031808.8A patent/CN109415683B/zh active Active
- 2017-04-11 US US16/093,041 patent/US11202807B2/en active Active
- 2017-04-11 PT PT177162534T patent/PT3443071T/pt unknown
- 2017-04-11 CA CA3020454A patent/CA3020454A1/en active Pending
-
2018
- 2018-10-10 IL IL262258A patent/IL262258B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EA201800564A1 (ru) | 2019-06-28 |
| US11202807B2 (en) | 2021-12-21 |
| PL3443071T3 (pl) | 2022-03-28 |
| BR112018070962A2 (pt) | 2019-01-29 |
| JP7012377B2 (ja) | 2022-02-14 |
| AU2017251253B2 (en) | 2023-01-05 |
| EP3443071A1 (en) | 2019-02-20 |
| IL262258B (en) | 2021-03-25 |
| US20190183941A1 (en) | 2019-06-20 |
| DK3443071T3 (da) | 2022-01-31 |
| CN109415683A (zh) | 2019-03-01 |
| EP3443071B1 (en) | 2022-01-05 |
| CN109415683B (zh) | 2022-04-15 |
| WO2017178496A1 (en) | 2017-10-19 |
| ES2905784T3 (es) | 2022-04-12 |
| AU2017251253A1 (en) | 2018-11-01 |
| KR20180133443A (ko) | 2018-12-14 |
| JP2019510520A (ja) | 2019-04-18 |
| MX2018012408A (es) | 2019-06-17 |
| CA3020454A1 (en) | 2017-10-19 |
| IL262258A (en) | 2018-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262258B (en) | A new bacterial species | |
| PL3380108T3 (pl) | Zaprojektowane kompozycje bakteryjne | |
| EP3535566C0 (en) | BIOSENSOR | |
| GB2600653B (en) | Novel methods | |
| SG11201705416XA (en) | Bacterial compositions | |
| DK3532170T3 (da) | Aerosolspray indeholdende levedygtige bakteriearter | |
| IL253635A0 (en) | Cyclopropanebenzofuranyl pyridopyrazinedione type compounds | |
| GB201617548D0 (en) | Novel biological factor | |
| GB201612242D0 (en) | Novel kit | |
| EP3260529A4 (en) | Incubator | |
| GB201603320D0 (en) | Enhancing photosynthesis | |
| EP3228697A4 (en) | Highly efficient ethanol-fermentative bacteria | |
| EP3550018A4 (en) | NEW ENDO-ß-N-ACETYLGLUCOSAMINIDASE | |
| EP3524656A4 (en) | NEW HYDROGEL | |
| EP3228698A4 (en) | Highly efficient ethanol-fermentative bacteria | |
| GB2571892B (en) | Incubator | |
| EP3228696A4 (en) | Highly efficient ethanol-fermentative bacteria | |
| EP3228699A4 (en) | Highly efficient ethanol-fermentative bacteria | |
| GB2571506B (en) | Microorganism | |
| GB201711892D0 (en) | Improved culture methods | |
| GB201715203D0 (en) | Novel methods | |
| GB201715089D0 (en) | Novel methods | |
| GB201712386D0 (en) | Novel Methods | |
| GB201712596D0 (en) | Improved photobioreactor | |
| GB201709694D0 (en) | Modified microorganisms |